Taylor Goodspeed focuses on regulatory, compliance, and civil litigation matters involving the health care industry. She counsels and defends hospitals, health systems, life science companies, and other health care entities in civil fraud and abuse investigations and litigation, particularly under the civil False Claims Act (FCA) and similar state laws. She helps steer clients through high-profile investigations from federal and state agencies.
Taylor also counsels corporations on mitigating human trafficking-related risks in corporate supply chains and implementing appropriate compliance training and employee policies and procedures on these topics. She conducts internal investigations and responds to governmental investigations involving human trafficking, and her practice extends to human trafficking-related litigation brought pursuant to the Trafficking Victims Protection Reauthorization Act (TVPRA). She has presented on issues of human trafficking in corporate supply chains, including in the health care and real estate industries.
Taylor also worked closely with the in-house legal team at a global biopharmaceutical company while on secondment in its litigation and government investigations group. During that time, she managed a wide variety of matters including civil litigation, interactions with enforcement authorities, and internal investigations across the globe.
Taylor maintains an active pro bono practice in the anti-trafficking space, serving on Jones Day's Anti-Human Trafficking Committee and on the American Hospital Association's (AHA) Human Trafficking Advisory Council. She also frequently presents on the Firm's pro bono anti-trafficking efforts.
Taylor is currently serving her second term as a member of the Women's Leadership Council for the American Health Law Association (AHLA).
JONES DAY TALKS®: Jones Day’s Anti-Human Trafficking Initiative: Health Care Supply Chains and Forced Labor
- University of Pennsylvania (J.D. 2017; Articles Editor, University of Pennsylvania Law Review; Master of Bioethics 2017, Perelman School of Medicine); Stanford University (B.A. in Human Biology 2012; B.A. in Classics 2012)
- New York and California